-
Shaping the future of UK company accounts
FRC publishes stakeholder insights on digital reporting.
-
What is the territorial scope of the Failure to Prevent Fraud Offence?
Considerations for compliance in large organizations.
-
Tackling fraud in Big Pharma: Realistic ambition or pipe dream?
Any suggestion of misleading clinical results, false advertising, or bribery to achieve medical approvals would clearly create massive negative publicity.
-
Changes to UK Economic Crime and Corporate Transparency Act explained
Companies House has made moves to improve transparency and ensure accuracy of information on registers.
-
OPINION: Failure to prevent fraud offence – well intentioned or naive?
Will the UK’s new failure to prevent fraud offence help or hinder companies? Tony McClements states his case.
-
Failure to prevent fraud to be a criminal offence in UK – will this be an effective deterrent?
The long-awaited Government Guidance is published – companies have until September 1, 2025 to implement “reasonable procedures”.
-
Opinion: Will common sense prevail in the UK’s long overdue review of disclosure rules?
Tony McClements makes a case for fraud investigators at the coalface to be helped to get the job done.
-
OPINION: UK SFO under the new director
UK SFO director Nick Ephgrave is making all the right noises in his quest to repurpose the organization says Tony McClements.